Low-fat vegan diet helps type 2 diabetes
A new study shows that an ad libitum low-fat vegan diet improves insulin sensitivity and reduces harmful fat in people with type 2 diabetes. The research, published in BMJ Open Diabetes Research & Care, found significant metabolic benefits from the 16-week dietary intervention.
Researchers from Hana K. and colleagues studied 25 adults with type 2 diabetes. Participants followed a low-fat plant-based diet without calorie restrictions. The study used non-invasive methods to measure changes in body composition and metabolic function. Hepatocellular and intramyocellular lipids were assessed with non-invasive 1H magnetic resonance spectroscopy (1H -MRS).
Body scans revealed a 6.0 kg average weight loss, a 4.2 kg reduction in fat mass, and a 290 cm³ decrease in visceral fat volume. Magnetic resonance spectroscopy showed a 33.0% drop in liver fat. These changes suggest a direct reduction of ectopic fat, which fat accumulates in organs where it does not belong.
The diet also improved key markers of diabetes management. Fasting insulin resistance, measured by the HOMA-IR index, decreased significantly by −2.5. Post-meal insulin sensitivity increased by +1.3 mg/min/kg. Pancreatic beta-cell function, which is often impaired in type 2 diabetes, showed marked improvement across several parameters, including insulin secretion at 6 and 7 mmol/L glucose, beta-cell glucose sensitivity, rate sensitivity, and potentiation factor.
The study also noted a reduction in tissue accumulation of advanced glycation end products (AGEs), compounds linked to diabetes complications. The tissue accumulation of advanced glycation end products (AGE score) reduced significantly by −0.4. These findings suggest that a low-fat vegan diet addresses multiple aspects of metabolic dysfunction simultaneously.
For individuals with type 2 diabetes, this dietary approach offers a practical strategy to improve metabolic health without the need for strict calorie counting. The combination of fat loss and restored insulin function points to a powerful tool for managing the disease. The mean body weight loss corresponds to a relative body weight loss of 6.6%, and the fat mass reduction was 4.2 kg with a 290 cm³ decrease in visceral fat volume.
The trial results indicate that ad libitum plant-based eating is an effective model for lowering ectopic lipids, AGEs, and insulin resistance. The study provides strong evidence for the metabolic benefits of a whole-foods, vegan diet in the context of type 2 diabetes management.
